Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2026-02-01 @ 4:45 AM
Study NCT ID:
NCT06090266
Status:
RECRUITING
Last Update Posted:
2025-01-07
First Post:
2023-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Sponsor:
OncoResponse, Inc.
Organization: